Jacobs Levy Equity Management
PVLA

Jacobs Levy Equity Management’s Palvella Therapeutics PVLA Stock Holding History

Jacobs Levy Equity Management’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,334
Closed -$17.7K – 1080
2023
Q2 		$17.7K Sell
1,334
-2,670
-67% -$162K ﹤0.01% 957
2023
Q1 		$313K Sell
4,004
-44
-1% -$5.09K ﹤0.01% 855
2022
Q4 		$337K Sell
4,048
-863
-18% -$69.3K ﹤0.01% 844
2022
Q3 		$452K Buy
4,911
+2,987
+155% +$385K ﹤0.01% 839
2022
Q2 		$288K Buy
+1,924
New +$351K ﹤0.01% 932
2021
Q4 		– Sell
-2,143
Closed -$886K – 1091
2021
Q3 		$886K Sell
2,143
-2,375
-53% -$827K 0.01% 772
2021
Q2 		$1.38M Sell
4,518
-2,242
-33% -$492K 0.01% 674
2021
Q1 		$1.39M Buy
6,760
+80
+1% +$17.5K 0.01% 667
2020
Q4 		$1.34M Buy
6,680
+1,909
+40% +$397K 0.01% 657
2020
Q3 		$790K Buy
4,771
+1,050
+28% +$239K 0.01% 705
2020
Q2 		$923K Sell
3,721
-47
-1% -$11K 0.01% 686
2020
Q1 		$687K Buy
3,768
+499
+15% +$126K 0.01% 701
2019
Q4 		$947K Buy
3,269
+1,713
+110% +$475K 0.01% 700
2019
Q3 		$425K Sell
1,556
-460
-23% -$178K 0.01% 741
2019
Q2 		$758K Sell
2,016
-82
-4% -$24.5K 0.01% 684
2019
Q1 		$562K Buy
+2,098
New +$498K 0.01% 766
2018
Q3 		– Sell
-531
Closed -$215K – 1090
2018
Q2 		$215K Buy
+531
New +$253K ﹤0.01% 944
2018
Q1 		– Sell
-154
Closed -$93K – 1069
2017
Q4 		$93K Buy
+154
New +$71.6K ﹤0.01% 955

Other funds holding PVLA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jacobs Levy Equity Management's PVLA Position: Q3 2023 in Review

Jacobs Levy Equity Management sold out of Palvella Therapeutics (PVLA) in Q3 2023, closing a stake of 1,334 shares — an estimated $17.7K sold.

Jacobs Levy Equity Management first reported a position in PVLA in Q4 2017 and held it in 18 quarters. The position peaked at $1.39M in Q1 2021. 43 funds tracked by Wall St. Rank hold PVLA as of Q3 2023.

  • Jacobs Levy Equity Management reported no remaining Palvella Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 1,334 Palvella Therapeutics shares in Q3 2023, an estimated $17.7K.
  • Jacobs Levy Equity Management first reported a position in Palvella Therapeutics in Q4 2017 and held it in 18 quarters.
  • Jacobs Levy Equity Management's Palvella Therapeutics position peaked at $1.39M in Q1 2021.
  • 43 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q3 2023.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2023, filed 17 Nov 2023.